Venrock Healthcare Capital Partners III L.P. 13D and 13G filings for enGene Holdings Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 6:15 pm Purchase |
2024-12-31 | 13G | enGene Holdings Inc. Common Stock ENGN |
Venrock Healthcare Capital Partners III L.P. | 5,046,414 9.900% |
1,480,573 (+41.52%) |
Filing |
| 2024-11-14 5:48 pm Purchase |
2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN |
Venrock Healthcare Capital Partners III L.P. | 3,565,841 8.100% |
1,000,000 (+38.97%) |
Filing |
| 2024-02-26 4:15 pm Purchase |
2024-02-16 | 13G | enGene Holdings Inc. Common Stock ENGN |
Venrock Healthcare Capital Partners III L.P. | 2,565,841 5.900% |
2,565,841 (New Position) |
Filing |